发明名称 IMMUNOMODULATION BY IAP INHIBITORS
摘要 PROBLEM TO BE SOLVED: To provide inhibitors of apoptosis protein (IAP) inhibitors that enhance the immune response in a subject when administered to the subject.SOLUTION: Provided is an IAP inhibitor to be used as a medicine for enhancing immune response in a subject, the IAP inhibitor being (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide, or a pharmaceutically acceptable salt thereof. Also provided is a use of the IAP inhibitor to enhance the immune response to cancer, where the immune enhancement includes cytokine production, and the cytokine may be IL-2 or interferon-γ.SELECTED DRAWING: None
申请公布号 JP2016094429(A) 申请公布日期 2016.05.26
申请号 JP20150236482 申请日期 2015.12.03
申请人 NOVARTIS AG;DANA-FARBER CANCER INSTITUTE INC 发明人 LEIGH ZAWEL;MICHAEL DOUGAN;GLENN DRANOFF;BRANT G FIRESTONE;CHRISTOPHER S STRAUB
分类号 A61K31/427;A61P35/00;A61P35/02;A61P37/04;A61P43/00 主分类号 A61K31/427
代理机构 代理人
主权项
地址